Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST)

Authors: Cathrine Hoyo, Amy P Murtha, Joellen M Schildkraut, Michele R Forman, Brian Calingaert, Wendy Demark-Wahnefried, Joanne Kurtzberg, Randy L Jirtle, Susan K Murphy

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Folic acid (FA) added to foods during fortification is 70-85% bioavailable compared to 50% of folate occurring naturally in foods. Thus, if FA supplements also are taken during pregnancy, both mother and fetus can be exposed to FA exceeding the Institute of Medicine's recommended tolerable upper limit (TUL) of 1,000 micrograms per day (μg/d) for adult pregnant women. The primary objective is to estimate the proportion of women taking folic acid (FA) doses exceeding the TUL before and during pregnancy, and to identify correlates of high FA use.

Methods

During 2005-2008, pre-pregnancy and pregnancy-related data on dietary supplementation were obtained by interviewing 539 pregnant women enrolled at two obstetrics-care facilities in Durham County, North Carolina.

Results

Before pregnancy, 51% of women reported FA supplementation and 66% reported this supplementation during pregnancy. Before pregnancy, 11.9% (95% CI = 9.2%-14.6%) of women reported supplementation with FA doses above the TUL of 1,000 μg/day, and a similar proportion reported this intake prenatally. Before pregnancy, Caucasian women were more likely to take FA doses above the TUL (OR = 2.99; 95% = 1.28-7.00), compared to African American women, while women with chronic conditions were less likely to take FA doses above the TUL (OR = 0.48; 95%CI = 0.21-0.97). Compared to African American women, Caucasian women were also more likely to report FA intake in doses exceeding the TUL during pregnancy (OR = 5.09; 95%CI = 2.07-12.49).

Conclusions

Fifty-one percent of women reported some FA intake before and 66% during pregnancy, respectively, and more than one in ten women took FA supplements in doses that exceeded the TUL. Caucasian women were more likely to report high FA intake. A study is ongoing to identify possible genetic and non-genotoxic effects of these high doses.
Literature
1.
Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, Gindler J, et al: Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. The New England journal of medicine. 1999, 341 (20): 1485-1490. 10.1056/NEJM199911113412001.CrossRefPubMed
2.
Czeizel AE, Dudas I: Prevention of the first occurence of neural-tube defects by periconceptional vitamin supplementation. The New England journal of medicine. 1992, 327 (26): 1832-1835. 10.1056/NEJM199212243272602.CrossRefPubMed
3.
4.
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991, 338 (8760): 131-137. 10.1016/0140-6736(91)90133-A.
5.
Timmermans S, Jaddoe VW, Hofman A, Steegers-Theunissen RP, Steegers EA: Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study. The British journal of nutrition. 2009, 1-9.
6.
(US) IoM: Institute of Medicine. Dietary reference intakes from thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, patothenic acid, biotin and choline. 1998, Washington, DC: National Academy Press
7.
CDC: Use of Supplements Containing Folic Acid Among Women of Childbearing Age --- United States, 2007. Mmwr. 2008, 57 (1): 5-8.
8.
Finer LB, Henshaw SK: Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on sexual and reproductive health. 2006, 38 (2): 90-96. 10.1363/3809006.CrossRefPubMed
9.
US Food and Drug Administration: Food Standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register. 1996, 61: 8781-8797.
10.
Crane NT, Wilson DB, Cook DA, Lewis CJ, Yetley EA, Rader JI: Evaluating food fortification options: general principles revisited with folic acid. American journal of public health. 1995, 85 (5): 660-666. 10.2105/AJPH.85.5.660.CrossRefPubMedPubMedCentral
11.
Lewis CJ, Crane NT, Wilson DB, Yetley EA: Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr. 1999, 70 (2): 198-207.PubMed
12.
Quinlivan EP, Gregory JF: Effect of food fortification on folic acid intake in the United States. Am J Clin Nutr. 2003, 77 (1): 221-225.PubMed
13.
Winkels RM, Brouwer IA, Siebelink E, Katan MB, Verhoef P: Bioavailability of food folates is 80% of that of folic acid. Am J Clin Nutr. 2007, 85 (2): 465-473.PubMed
14.
Caudill MA, Le T, Moonie SA, Esfahani ST, Cogger EA: Folate status in women of childbearing age residing in Southern California after folic acid fortification. J Am Coll Nutr. 2001, 20 (2 Suppl): 129-134.CrossRefPubMed
15.
Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH: The effect of folic acid fortification on plasma folate and total homocysteine concentrations. The New England journal of medicine. 1999, 340 (19): 1449-1454. 10.1056/NEJM199905133401901.CrossRefPubMed
16.
Carmichael SL, Shaw GM, Yang W, Laurent C, Herring A, Royle MH, Canfield M: Correlates of intake of folic acid-containing supplements among pregnant women. American journal of obstetrics and gynecology. 2006, 194 (1): 203-210. 10.1016/j.ajog.2005.06.018.CrossRefPubMedPubMedCentral
17.
Forster DA, Wills G, Denning A, Bolger M: The use of folic acid and other vitamins before and during pregnancy in a group of women in Melbourne, Australia. Midwifery. 2009, 25 (2): 134-146. 10.1016/j.midw.2007.01.019.CrossRefPubMed
18.
Nilsen RM, Vollset SE, Gjessing HK, Magnus P, Meltzer HM, Haugen M, Ueland PM: Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian Mother and Child Cohort Study. The American journal of clinical nutrition. 2006, 84 (5): 1134-1141.PubMed
19.
Botto LD, Olney RS, Erickson JD: Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet. 2004, 125C (1): 12-21. 10.1002/ajmg.c.30004.CrossRefPubMed
20.
Goh YI, Bollano E, Einarson TR, Koren G: Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can. 2006, 28 (8): 680-689.CrossRefPubMed
21.
Wilson RD, Johnson JA, Wyatt P, Allen V, Gagnon A, Langlois S, Blight C, Audibert F, Desilets V, Brock JA, et al: Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007, 29 (12): 1003-1026.CrossRefPubMed
22.
Gabriel HE, Crott JW, Ghandour H, Dallal GE, Choi SW, Keyes MK, Jang H, Liu Z, Nadeau M, Johnston A, et al: Chronic cigarette smoking is associated with diminished folate status, altered folate form distribution, and increased genetic damage in the buccal mucosa of healthy adults. Am J Clin Nutr. 2006, 83 (4): 835-841.PubMed
23.
Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD: Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr. 2007, 85 (5): 1409-1416.PubMed
24.
McGuire M, Cleary B, Sahm L, Murphy DJ: Prevalence and predictors of periconceptional folic acid uptake--prospective cohort study in an Irish urban obstetric population. Human reproduction (Oxford, England). 25 (2): 535-543. 10.1093/humrep/dep398.
25.
North Carolina Reported Pregnancies - 2006. 2006, North Carolina Dept. of Health and Human Services, State Center for Health Statistics
26.
Ulrich CM: Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr. 2007, 86 (2): 271-273.PubMed
27.
Czeizel AE, Metneki J, Dudas I: Higher rate of multiple births after periconceptional vitamin supplementation. The New England journal of medicine. 1994, 330 (23): 1687-1688. 10.1056/NEJM199406093302314.CrossRefPubMed
28.
Ericson A, Kallen B, Aberg A: Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res. 2001, 4 (2): 63-66. 10.1375/1369052012155.CrossRefPubMed
29.
Vollset SE, Gjessing HK, Tandberg A, Ronning T, Irgens LM, Baste V, Nilsen RM, Daltveit AK: Folate supplementation and twin pregnancies. Epidemiology. 2005, 16 (2): 201-205. 10.1097/01.ede.0000152914.84962.13.CrossRefPubMed
30.
Lucock M, Yates Z: Folic acid - vitamin and panacea or genetic time bomb?. Nature reviews. 2005, 6 (3): 235-240. 10.1038/nrg1558.CrossRefPubMed
31.
Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S, Reyes-Engel A: Genetic selection and folate intake during pregnancy. Lancet. 1998, 352 (9134): 1120-1121. 10.1016/S0140-6736(05)79761-0.CrossRefPubMed
32.
Gilbody S, Lewis S, Lightfoot T: Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. American journal of epidemiology. 2007, 165 (1): 1-13. 10.1093/aje/kwj347.CrossRefPubMed
33.
Lewis SJ, Lawlor DA, Davey Smith G, Araya R, Timpson N, Day IN, Ebrahim S: The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Molecular psychiatry. 2006, 11 (4): 352-360. 10.1038/sj.mp.4001790.CrossRefPubMed
34.
Muntjewerff J, Blom HJ: Aberrant folate status in schizophrenic patients: what is the evidence?. Progress in neuro-psychopharmacology & biological psychiatry. 2005, 29 (7): 1133-1139.CrossRef
35.
Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W: Folic acid supplements in pregnancy and early childhood respiratory health. Archives of disease in childhood. 2009, 94 (3): 180-184. 10.1136/adc.2008.142448.CrossRefPubMed
36.
Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, Steegers EA, Slagboom PE, Heijmans BT: Periconceptional Maternal Folic Acid Use of 400 microg per Day Is Related to Increased Methylation of the IGF2 Gene in the Very Young Child. PLoS One. 2009, 4 (11): e7845-10.1371/journal.pone.0007845.CrossRefPubMedPubMedCentral
37.
DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP: Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. American journal of human genetics. 2002, 70 (3): 604-611. 10.1086/338934.CrossRefPubMedPubMedCentral
38.
Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR, Feinberg AP: Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (New York, NY. 2003, 299 (5613): 1753-1755. 10.1126/science.1080902.CrossRef
39.
D'Angelo D, Williams L, Morrow B, Cox S, Harris N, Harrison L, Posner SF, Hood JR, Zapata L: Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ. 2007, 56 (10): 1-35.PubMed
40.
Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG, Bentley ME: Pill count adherence to prenatal multivitamin/mineral supplement use among low-income women. J Nutr. 2005, 135 (5): 1093-1101.PubMed
41.
Bodnar LM, Tang G, Ness RB, Harger G, Roberts JM: Periconceptional multivitamin use reduces the risk of preeclampsia. American journal of epidemiology. 2006, 164 (5): 470-477. 10.1093/aje/kwj218.CrossRefPubMed
42.
Green-Raleigh K, Lawrence JM, Chen H, Devine O, Prue C: Pregnancy planning status and health behaviors among nonpregnant women in a California managed health care organization. Perspectives on sexual and reproductive health. 2005, 37 (4): 179-183. 10.1363/3717905.CrossRefPubMed
43.
Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF: Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. American journal of epidemiology. 2004, 160 (4): 339-349. 10.1093/aje/kwh207.CrossRefPubMed
44.
de Jong-Van den Berg LT, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA: Trends and predictors of folic acid awareness and periconceptional use in pregnant women. American journal of obstetrics and gynecology. 2005, 192 (1): 121-128. 10.1016/j.ajog.2004.05.085.CrossRefPubMed
45.
Bentley TG, Willett WC, Weinstein MC, Kuntz KM: Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. American journal of public health. 2006, 96 (11): 2040-2047. 10.2105/AJPH.2005.067371.CrossRefPubMedPubMedCentral
46.
Behavioral Risk Factor Surveillance System Survey Data. 2007, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention
47.
McDonnell R, Johnson Z, Doyle A, Sayers G: Determinants of folic acid knowledge and use among antenatal women. Journal of public health medicine. 1999, 21 (2): 145-149. 10.1093/pubmed/21.2.145.CrossRefPubMed
48.
Braekke K, Staff AC: Periconceptional use of folic acid supplements in Oslo. Acta obstetricia et gynecologica Scandinavica. 2003, 82 (7): 620-627.CrossRefPubMed
Metadata
Title
Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST)
Authors
Cathrine Hoyo
Amy P Murtha
Joellen M Schildkraut
Michele R Forman
Brian Calingaert
Wendy Demark-Wahnefried
Joanne Kurtzberg
Randy L Jirtle
Susan K Murphy
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-46

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue

Research article

Economic impacts of illness in older workers: quantifying the impact of illness on income, tax revenue and government spending

Research article

Costs and longer-term savings of parenting programmes for the prevention of persistent conduct disorder: a modelling study

Study protocol

The Cool Little Kids randomised controlled trial: Population-level early prevention for anxiety disorders

Research article

A qualitative exploration of the human resource policy implications of voluntary counselling and testing scale-up in Kenya: applying a model for policy analysis

Research article

Low usage of government healthcare facilities for acute respiratory infections in guatemala: implications for influenza surveillance

Research article

Nationwide shifts in the double burden of overweight and underweight in Vietnamese adults in 2000 and 2005: two national nutrition surveys